TQ Quiz | Off-Label Medication Use in Optometric Practice (Orlando 2023) by Events@optometricedu.com | Jun 19, 2023 | 2023 Orlando, TQ Courses | 0 comments "*" indicates required fields Hidden@{:35}HiddenDate (Hidden) MM slash DD slash YYYY HiddenEvent Date (Hidden) MM slash DD slash YYYY HiddenEvent 60 days past date (Hidden) MM slash DD slash YYYY HiddenEvent Date Difference (Hidden)1. Which organization is responsible for the approval of prescription drugs?* A - FDA B - USDA C - FTC D - FEMA 2. Use of a medication to treat a condition that is not included under FDA-approval is known as what?* A - Illegal B - Off-label use C - Supplementation D - Apothecary-recommended 3. _____________ is the study of how a drug affects the body.* A - Pharmacokinetics B - Phrenology C - Pharmacodynamics D - Iridology 4. Fourth-generation fluoroquinolones are FDA-approved for what ocular condition?* A - Bacterial conjunctivitis B - Epidemic keratoconjunctivitis C - Acute angle closure glaucoma D - Myokymia 5. What medication used to treat neovascular retinal disorders and retinal edema was referred to as the crown-prince of ophthalmic off-label use?* A - Bevacizumab (Avastin) B - Omega-6 supplements C - Flintstones chewable multi-vitamins D - Refresh Plus 6. Which off-label uses of topical azithromycin (AzaSite 1%) were discussed?* A - Bacterial conjunctivitis B - Ptosis C - Cystoid macular edema D - Dry-eye related blepharitis 7. Ganciclovir (Zirgan 0.15%) has shown promise as an off-label treatment of what ocular condition?* A - Bacterial corneal ulcer B - Epidemic keratoconjunctivitis C - Severe dry eye syndrome D - Reduction in ischemic injury due to retinal vein occlusion 8. Difluprednate (Durezol 0.05%) is FDA-approved for which ophthalmic condition?* A - Pterygium B - Filamentary keratitis C - Post-surgical inflammation D - Iritis secondary to systemic inflammatory condition 9. What micronutrient was the focus of the Graves’ disease supplementation (GRASS) trial?* A - Tryptophan B - Omega -6 C - Calcium D - Selenium 100 µg BID 10. L-lysine 500mg BID has been suggested to hamper the activity of arginine and decrease the severity of __________________* A - Migraine headaches B - Allergic rhinitis C - Herpes simplex virus D - Myokymia 11. ________________ belongs to a class of medications known as antimycobaterials and has also shown promise in the treatment of chronic, non-resolving CSC?* A - Rimfampin B - Toprimate C - Ibuprofen D - Fexofenadine 12. Doxycycline has been studied in the treatment of what following ophthalmic conditions?* A - Recurrent corneal erosions (RCE) B - Meibomian gland dysfunction (MGD) C - Dry eye syndrome (DES) D - All of the Above 13. Migraine management has been studied using which of the following topical medications?* A - Dorzolamide B - Timolol 0.5% C - Prednisolone acetate D - Lifitigrast 14. Dorzolamide + Timolol used as adjuvant therapy was found to be effective in which ophthalmic diagnosis?* A - Convergence insufficiency B - Ptosis C - Macular edema related to retina vein occlusion and exudative AMD D - Anisocoria 15. High-dosage atorvastatin has been suggested to have a positive effect in the management of what ophthalmic condition?* A - Atrophic age-related macular degeneration B - Recurrent corneal erosion C - Chronic uveitis D - Angle-closure glaucoma 16. Apraclonodine (Iopidine 1%) is used off-label in the differential diagnosis of what neuro-ophthalmic condition?* A - Syphilis B - Cat scratch fever C - Mild traumatic brain injury D - Horner’s syndrome 17. Topical corticosteroids demonstrate a strong anti-inflammatory component that can be effectively utilized in the treatment of what ophthalmic condition?* A - Retinal Pigmented Epithelial Dysfunction B - Moderate to severe dry-eye syndrome C - Fuch’s dystrophy D - Age-related macular degeneration 18. Prostaglandin analogues can be used to mitigate corneal edema by decreasing IOP in what corneal condition?* A - EBMD B - Superficial punctate keratitis C - Fuch’s dystrophy D - Both A and B 19. Chronic, non-resolving central serous chorioretinopathy has shown a positive therapeutic response when treated with what class of oral medications?* A - Mineralocorticoid antagonists B - Protein supplements C - AREDS2 formulations D - Beta-blockers 20. Cyclosporine (Restais 0.05%) has a number of off-label uses including:* A - Atopic keratoconjunctivitis B - Corneal graft-host rejection C - Post-surgical dryness D - All of the Above Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationHiddenRetake Code @{:35} | TQ Credit*After @{:59}, pricing will increase to $30. Price: (Past 60 Days) @{:35} | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: (Past 60 Days) Retake Discount Price: Paying Via Credit Card A Paypal account is not required to pay using the button below. To pay using a credit card, click the Paypal button below. A new window will appear and a button "Pay with Debit or Credit Card" is available at the bottom of that window for your convenience. Payment MethodHiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenRetake Code (HIDDEN) HiddenQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/) HiddenCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website